FDA Recall Terminated

Variant II Turbo Hemoglobin A1c Program, model number 270 2417, manufactured by Bio-Rad Laboratories, Inc, Hercules, CA. Intended Use: For the percent determination of hemoglobin A1c in human whole blood using ion-exchange high-performance liquid chromatography (HPLC).

Recall: Z-0867-2010 · Initiated October 12, 2009

Recall

Recall Number
Z-0867-2010
Event Number
53649
Firm
Bio-Rad Laboratories Inc
FEI Number
2915274
Product Code
LCP
Status
Terminated
Root Cause
Other
Initiated
October 12, 2009
Posted
February 26, 2010
Terminated
December 17, 2010
Address
4000 Alfred Nobel Dr, Hercules, CA, 94547-1803

Description

Variant II Turbo Hemoglobin A1c Program, model number 270 2417, manufactured by Bio-Rad Laboratories, Inc, Hercules, CA. Intended Use: For the percent determination of hemoglobin A1c in human whole blood using ion-exchange high-performance liquid chromatography (HPLC).

Reason

Product update kit CD rom will not upload. As a result, the device cannot be run.

Action

The firm initiated this action on 10/12/2009. Consignees were contacted by phone with a fax follow up. Subsidiaries, as well as consignees that received the product, were provided with a Medical Device Correction notice, dated October 13, 2009, and response form. Each subsidiary will contact customers. The letter asks customers to destroy the affected lot included with their reorder packs and replace them with the lot number that's enclosed. Customers are to complete the Customer Medical Device Correction Response Form and fax it to Bio-Rad CSD Regulatory Affairs Department at the number provided. Questions should be directed to customers' regional Bio-Rad office.

Distribution

Worldwide Distribution -- USA, Hong Kong, and New Zealand.

Quantity

21 kits